Warning: The NCBI web site requires JavaScript to function. more...
Prescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control study.
Cronin-Fenton DP, Pedersen L, Lash TL, Friis S, Baron JA, Sørensen HT.
Breast Cancer Res. 2010;12(2):R15. Epub 2010 Mar 1.
Related citations
Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study.
Moride Y, Ducruet T, Boivin JF, Moore N, Perreault S, Zhao S.
Arthritis Res Ther. 2005;7(2):R333-42. Epub 2005 Jan 17.
Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancer.
Rahme E, Ghosn J, Dasgupta K, Rajan R, Hudson M.
BMC Cancer. 2005 Dec 12;5:159.
Risk of colorectal cancer in patients prescribed statins, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 inhibitors: nested case-control study.
Vinogradova Y, Hippisley-Cox J, Coupland C, Logan RF.
Gastroenterology. 2007 Aug;133(2):393-402. Epub 2007 May 21.
Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk.
Terry MB, Gammon MD, Zhang FF, Tawfik H, Teitelbaum SL, Britton JA, Subbaramaiah K, Dannenberg AJ, Neugut AI.
JAMA. 2004 May 26;291(20):2433-40.
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors.
Harris RE, Beebe-Donk J, Alshafie GA.
BMC Cancer. 2006 Jan 30;6:27.
Reduced risk of human lung cancer by selective cyclooxygenase 2 (COX-2) blockade: results of a case control study.
Int J Biol Sci. 2007 Jun 13;3(5):328-34.
"Selective" switching from non-selective to selective non-steroidal anti-inflammatory drugs.
Bennett K, Teeling M, Feely J.
Eur J Clin Pharmacol. 2003 Nov;59(8-9):645-9. Epub 2003 Aug 27.
A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling.
Brown TJ, Hooper L, Elliott RA, Payne K, Webb R, Roberts C, Rostom A, Symmons D.
Health Technol Assess. 2006 Oct;10(38):iii-iv, xi-xiii, 1-183. Review.
Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study.
Johnsen SP, Larsson H, Tarone RE, McLaughlin JK, Nørgård B, Friis S, Sørensen HT.
Arch Intern Med. 2005 May 9;165(9):978-84.
Final Report on Carcinogens Background Document for Styrene.
Rep Carcinog Backgr Doc. 2008 Sep;(8-5978):i-398.
Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review).
Harris RE, Beebe-Donk J, Doss H, Burr Doss D.
Oncol Rep. 2005 Apr;13(4):559-83. Review.
Aspirin and other nonsteroidal anti-inflammatory drugs in relation to Hodgkin lymphoma risk in northern Denmark.
Chang ET, Cronin-Fenton DP, Friis S, Hjalgrim H, Sørensen HT, Pedersen L.
Cancer Epidemiol Biomarkers Prev. 2010 Jan;19(1):59-64.
COX-2-selective inhibitors and the risk of upper gastrointestinal bleeding in high-risk patients with previous gastrointestinal diseases: a population-based case-control study.
Nørgård B, Pedersen L, Johnsen SP, Tarone RE, McLaughlin JK, Friis S, Sørensen HT.
Aliment Pharmacol Ther. 2004 Apr 1;19(7):817-25.
Evaluation of risk profiles for gastrointestinal and cardiovascular adverse effects in nonselective NSAID and COX-2 inhibitor users: a cohort study using pharmacy dispensing data in The Netherlands.
Layton D, Souverein PC, Heerdink ER, Shakir SA, Egberts AC.
Drug Saf. 2008;31(2):143-58.
Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study.
Gierach GL, Lacey JV Jr, Schatzkin A, Leitzmann MF, Richesson D, Hollenbeck AR, Brinton LA.
Breast Cancer Res. 2008;10(2):R38. Epub 2008 Apr 30.
Association between non-steroidal anti-inflammatory drugs (NSAIDs) and invasive breast cancer and carcinoma in situ of the breast.
Moorman PG, Grubber JM, Millikan RC, Newman B.
Cancer Causes Control. 2003 Dec;14(10):915-22.
Nonsteroidal anti-inflammatory drug use and breast cancer risk: a Danish cohort study.
Friis S, Thomassen L, Sørensen HT, Tjønneland A, Overvad K, Cronin-Fenton DP, Vogel U, McLaughlin JK, Blot WJ, Olsen JH.
Eur J Cancer Prev. 2008 Apr;17(2):88-96.
A nationwide study of aspirin, other non-steroidal anti-inflammatory drugs, and Hodgkin lymphoma risk in Denmark.
Chang ET, Frøslev T, Sørensen HT, Pedersen L.
Br J Cancer. 2011 Nov 22;105(11):1776-82. doi: 10.1038/bjc.2011.443. Epub 2011 Oct 25.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on